Elucidating pharmacodynamic interaction of silver nanoparticle - Topical deliverable antibiotics

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Thirumurugan, G ^a,b   Seshagiri Rao, J V L N ^c   Dhanaraju, M D ^b  

^a JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^b GIET School of Pharmacy   (India)

^c ANDHRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METAL NANOPARTICLE; POTASSIUM; REACTIVE OXYGEN METABOLITE; SILVER;

BIOFILM; DRUG EFFECT; ESCHERICHIA COLI; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; BIOFILMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; POTASSIUM; PSEUDOMONAS AERUGINOSA; REACTIVE OXYGEN SPECIES; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 84978946864     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29982     Document Type: Article

References (21)

1. Baxter, K. Stockley's Drug Interactions, ninth ed. (Pharmaceutical Press, London, 2010).
2. Kmeid, J. G. et al. Combination therapy for Gram-negative bacteria: what is the evidence? Expert Rev Anti Infect Ther. 11, 1355-1362 (2013).
3. Silver, S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 27, 341-353 (2003).
4. Kim, J. S. et al. Antimicrobial effects of silver nanoparticles. Nanomed. Nanotechnol. Biol. Med. 3, 95-101 (2007).
5. Martínez-Castañón, G. A. et al. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanoparticle Res. 10(8), 1343-1348 (2008).
6. Thirumurugan, G. et al. Superior wound healing effect of topically delivered silver nanoparticle formulation using eco-friendly potato plant pathogenic fungus: Synthesis and characterization. J. Biomed. Nanotechnol 7, 659-666 (2011).
7. Shrivastava, S. et al. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 18, 225103-225112 (2007).
8. Ruparelia, J. P. et al. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater 4, 707-716 (2008).
9. Fayaz, A. M. et al. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against grampositive and gram-negative bacteria. Nanomedicine: Nanotechnology, Biology and Medicine 6(1), 103-109 (2010).
10. Serge, R. et al. Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides. Antimicrob. Agents Chemother 53(8), 3538-3540 (2009).
11. Raja, R. B. et al. Synergistic effect of silver nanoparticles with the cephalexin antibiotic against the test strains. Bioresearch Bulletin 2(4), 1-8 (2013).
12. Kohanski, M. A. et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007).
13. In-sok Hwang. et al. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J. Med. Microbiol 61, 1719-1726 (2012).
14. Bortner, C. D. & Cidlowski, J. A. Caspase independent/dependent regulation of K(+), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis. J. Biol. Chem. 27421953-2196210. 1074/jbc. 274. 31. 21953 (1999).
15. Tiwari, D. K., Behari, J. & Sen, P. Time and dose-dependent antimicrobial potential of Ag nanoparticles synthesized by topdown approach. Curr Sci. 95, 647-655 (2008).
16. Guilhelmelli, F. et al. Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Frontiers in Microbiology 4, 353 (2013).
17. Chan, C., Burrows, L. L. & Deber, C. M. Helix induction in antimicrobial peptides by alginate in biofilms. J. Biol. Chem. 279 (2004).
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 6th ed. Approved standard M7-A6 (M100-S7). Wayne, Pa: National Committee for Clinical Laboratory Standards. (1997).
19. Odds, F. C. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52, 1 (2003).
20. Thirumurugan, G. et al. Comparative efficacy evaluation of seven commercial injectable ceftriaxone purchased at Ambo, Oromia Regional State, Ethiopia, using agar well plate diffusion method. Journal of Pharmaceutical Health Services Research 6(2), 97-101 (2015).
21. Dill, B. D. et al. Identification of iron-responsive proteins expressed by Chlamydia trachomatis reticulate bodies during intracellular growth. Microbiology 155(1), 210 (2009).